Theodore Prentice
Neurology · Santa Monica, CANPI 1194733436
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,016 of the $9,006 with a category attached, or 89.0%. It is spread thinly across 36 manufacturers, the largest accounting for just 10.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,486 and has fallen 98.4% since, to $57 in 2023.
Across 570 payments — averaging $15.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$966
- Teva Pharmaceuticals USA, Inc.$921
- Sunovion Pharmaceuticals Inc.$792
- Supernus Pharmaceuticals, Inc.$678
- AbbVie$655
- Novartis$550
- plus $4K from 30 others
What the payments were for
- Speaking & faculty fees$6717%
- Food & beverage$8,01689%
- Education$3184%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 86 | $966 |
| Teva Pharmaceuticals USA, Inc. | 69 | $921 |
| Sunovion Pharmaceuticals Inc. | 57 | $792 |
| Supernus Pharmaceuticals, Inc. | 6 | $678 |
| AbbVie(2 entities) | 50 | $655 |
| Novartis | 22 | $550 |
| Neurocrine Biosciences, Inc. | 31 | $470 |
| Biogen | 18 | $456 |
| SK Life Science, Inc. | 25 | $401 |
| Livanova USA, Inc. | 45 | $359 |
| Acadia Pharmaceuticals Inc | 28 | $332 |
| Amneal Pharmaceuticals LLC | 6 | $295 |
| Kyowa Kirin, Inc. | 12 | $256 |
| EMD Serono, Inc. | 23 | $231 |
| Adamas Pharmaceuticals, Inc. | 14 | $213 |
| Acorda Therapeutics, Inc | 11 | $205 |
| Aquestive Therapeutics, Inc. | 10 | $166 |
| AstraZeneca(2 entities) | 4 | $153 |
| Eisai Inc. | 17 | $122 |
| Abbott | 4 | $120 |
| Avanir Pharmaceuticals, Inc. | 5 | $97 |
| Genentech USA, Inc. | 4 | $90 |
| Amgen | 3 | $77 |
| Boston Scientific | 3 | $64 |
| Neurelis, Inc. | 3 | $47 |
| Sanofi | 2 | $45 |
| Lilly USA, LLC | 2 | $43 |
| MDD US Operations, LLC | 2 | $41 |
| Biohaven Pharmaceuticals, Inc. | 1 | $26 |
| Banner Life Sciences, LLC | 1 | $24 |
| Greenwich Biosciences, Inc. | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Mallinckrodt Enterprises LLC | 1 | $17 |
| Medtronic | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OXTELLAR XR$628
- TECFIDERA$136
- AUSTEDO$126
- RYTARY$125
How this compares
$9,006 in reported general payments places this provider in the 75th percentile of 1,996 neurology providers in California.
Other neurology in Santa Monica
- David KudrowSanta Monica$532K
- Santosh KesariSanta Monica$397K
- Andrew WooSanta Monica$273K
- Danny BenmosheSanta Monica$268K
- Andrew BlumenfeldCarlsbad$4.9M
- Khashayar DashtipourLoma Linda$3.3M
- Regina BerkovichWest Hollywood$3M
- Daniel BandariNewport Beach$2.6M
- Perry ShiehLos Angeles$2.4M
- Sandeep ThakkarIrvine$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.